If I Could Only Buy 1 Healthcare Stock in January, It Would Be This One
Pfizer Inc. (NYSE: PFE) is the one healthcare stock I'd add to my portfolio in January. Why? The company's turning the corner back toward growth, its R&D team is delivering important wins, its dividend is growing, and the company's getting a windfall thanks to the recently passed Tax and Jobs Act of 2017. Overall, I believe a very good argument can be made for including Pfizer in growth, value, and income portfolios sooner rather than later.
Lipitor's loss of patent protection in 2011 was a big blow. The cholesterol drug has seen its sales slip from $13 billion to around $2 billion over the past decade, and that decline has more than offset any revenue growth that's come from label expansions and new drug launches.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Pfizer Inc. Aktie
Die Community zeigt großes Interesse an Pfizer Inc. mit vielen Buy- und wenigen Sell-Einschätzungen.
Eine deutliche Steigerung um mehr als 50% ist für Pfizer Inc. mit einem Kursziel von 41 € gegenüber 26.0 € zu erwarten.
